Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [4]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- TA342210 - Provider product page
- Provider
- OriGene
- Product name
- Rabbit polyclonal Anti-RAB1A Antibody
- Antibody type
- Polyclonal
- Description
- Rabbit polyclonal Anti-RAB1A Antibody
- Host
- Rabbit
- Conjugate
- Unconjugated
- Epitope
- RAB1A
- Isotype
- IgG
- Antibody clone number
- NULL
- Vial size
- 100 µl
- Concentration
- 1mg/ml
No comments: Submit comment
Supportive validation
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- WB Suggested Anti-RAB1A Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:312500; Positive Control: Human Muscle
- Validation comment
- WB
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Sample Type: 1. Human Cervical Cancer Cell Lysate (15ug); 2. Monkey Fibroblast Cell Lysate (15ug); 3. Human Cervical Cancer Cell transfected with Rab1A-GFP (15ug); Primary Dilution: 1:1000; Secondary Antibody: goat anti-Rabbit; Secondary Dilution: 1:40,00
- Validation comment
- WB
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Host: Rabbit; Target Name: RAB1A; Sample Tissue: HepG2; Antibody Dilution: 1.0 ug/ml
- Validation comment
- WB
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Host: Rabbit; Target Name:RAB1A; Sample Tissue:HepG2; Lane A: Primary Antibody; Lane B: Primary Antibody + Blocking Peptide ; Primary Antibody Concentration:2 ug/ml; Peptide Concentration: 5.0 ug/ml; Lysate Quantity: 25ug/lane/lane; Gel Concentration: 12%
- Validation comment
- WB
Supportive validation
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Rabbit Anti-RAB1A Antibody;Formalin Fixed Paraffin Embedded Tissue: Human Bronchial Epithelial Tissue; Observed Staining: Cytoplasmic in excellent staining; Primary Antibody Concentration: 1:100; Secondary Antibody: Donkey anti-Rabbit-Cy3; Secondary Antib
- Validation comment
- IHC